Cidara Therapeutics (CDTX) announced that Nicole Davarpanah, M.D., J.D. has been promoted to chief medical officer, CMO, and Corrina Pavetto has been promoted to senior vice president, clinical development, effective May 1, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDTX:
- Elicio Therapeutics appoints Preetam Shah as chief strategy, financial officer
- Positive Buy Rating for Cidara Therapeutics Driven by Promising CD388 Development and Safety Profile
- Cidara Therapeutics to present on CD388 at ICAR 2025
- Cidara Therapeutics: CD388 preclinical data published in Nature Microbiology
- Cidara Therapeutics initiated with an Outperform at Citizens JMP